Overview
Heidi Rula is a Family Medicine provider in Chandler, Arizona. Dr. Rula is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Malignant Mixed Mullerian Tumor, Testicular Yolk Sac Tumor, Ovarian Cancer, and Virilizing Ovarian Tumor.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
695 S Dobson Rd, Chandler, AZ 85224
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- BRCA Positive Breast CancerDr. Rula isExperienced. Learn about BRCA Positive Breast Cancer.
- Classical Hodgkin LymphomaDr. Rula isExperienced. Learn about Classical Hodgkin Lymphoma.
- Endometrial CancerDr. Rula isExperienced. Learn about Endometrial Cancer.
- Endometrial Stromal SarcomaDr. Rula isExperienced. Learn about Endometrial Stromal Sarcoma.
- Gallbladder AdenocarcinomaDr. Rula isExperienced. Learn about Gallbladder Adenocarcinoma.
- HER2 Negative Breast CancerDr. Rula isExperienced. Learn about HER2 Negative Breast Cancer.